GME vs ZYME · P/E 16, rev $3.63B vs rev $106.0M
GameStop Corp. (GME) versus Zymeworks Inc. Common Stock (ZYME) — a side-by-side from cached financials, not a winner call.
GameStop Corp. (GME) is a specialty retail company listed on US.
Zymeworks Inc. Common Stock (ZYME) is a biotechnology company listed on NASDAQ.
Latest reported GME revenue for 2026-01-31 was $3.63B. Net income was $418.4M. Revenue was down 5.1% from 2025-02-01 to 2026-01-31. GME currently screens at market cap $9.78B and trailing P/E 16.3.
Latest reported ZYME revenue for 2025-12-31 was $106.0M. Net income was -$81.1M. Revenue was up 38.9% from 2024-12-31 to 2025-12-31. ZYME currently screens at market cap $1.68B.
GME currently screens at market cap $9.78B and trailing P/E 16.3. ZYME currently screens at market cap $1.68B.
Not investment advice. Open the GME and ZYME stock pages for the full models.
Not investment advice.